Literature DB >> 2984403

Hydroxylapatite as an alloplastic graft in the treatment of human periodontal osseous defects.

R M Meffert, J R Thomas, K M Hamilton, C N Brownstein.   

Abstract

Twelve patients, 32 to 60 years of age, received a polycrystalline ceramic form of pure dense hydroxylapatite as an alloplastic bone implant material in intrabony defects following reflection of full mucoperiosteal flaps, root planing and defect-curettement. The defects were measured from an acrylic stent, using an endodontic silver point which was placed to the base of the defect. Similarly, debrided and curetted defects in the same patients were not implanted and served as controls. Recalls for documentation and plaque control were at 1, 2, and 4 weeks, and at 3, 6 and 9 months. Measurements relating to changes in defect-depth were made upon reentry at 9 months. The twelve defects, serving as controls, showed very little difference between the pretherapy and 9-month measurements. The initial mean measurement from the base of the defect to the highest alveolar crest was 4.27 mm and the 9-month mean measurement after curettage only was 3.36 mm. In terms of resolution of the original defect this amounted to 19.49% reduction, but a 0.46-mm mean loss in height of the alveolar crest provided an actual percentage fill of the original defect of 9.91%. Of sixteen experimental defects, the same initial mean measurement from the base of the defect to the highest alveolar crest was 5.18 mm and the 9-month mean measurement after grafting was 2.43 mm. In terms of resolution of the original defect, this amounted to a 53.57% reduction, but in contradistinction to the curettage sites, a mean increase in height of the highest alveolar crest of 0.61 mm gave a true percentage fill of the original defect of 66.89%. At the 9-month reentry, the implanted mass seemed to be partially "calcified" and was resistant to penetration with a probe or removal with a curette. The data and clinical impression strongly suggest that hydroxylapatite has a potential as an alloplastic implant with clinically apparent acceptance by the soft and hard tissues.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2984403     DOI: 10.1902/jop.1985.56.2.63

Source DB:  PubMed          Journal:  J Periodontol        ISSN: 0022-3492            Impact factor:   6.993


  27 in total

Review 1.  Biomaterials in orthopaedics.

Authors:  M Navarro; A Michiardi; O Castaño; J A Planell
Journal:  J R Soc Interface       Date:  2008-10-06       Impact factor: 4.118

2.  Clinical effects of nanocrystalline hydroxyapatite paste in the treatment of intrabony periodontal defects: a randomized controlled clinical study.

Authors:  Bernd Heinz; Adrian Kasaj; Marie Teich; Søren Jepsen
Journal:  Clin Oral Investig       Date:  2009-08-13       Impact factor: 3.573

3.  Biomaterials in periodontal osseous defects.

Authors:  Nand Lal; Jaya Dixit
Journal:  J Oral Biol Craniofac Res       Date:  2012 Jan-Apr

Review 4.  Advanced reconstructive technologies for periodontal tissue repair.

Authors:  Christoph A Ramseier; Giulio Rasperini; Salvatore Batia; William V Giannobile
Journal:  Periodontol 2000       Date:  2012-06       Impact factor: 7.589

5.  Comparison of Nano-Sized Hydroxyapatite and β-Tricalcium Phosphate in the Treatment of Human Periodontal Intrabony Defects.

Authors:  Rohit Jain; Harjit Kaur; Sanjiv Jain; Diljit Kapoor; Tarun Nanda; Megha Jain
Journal:  J Clin Diagn Res       Date:  2014-10-20

6.  Biograft-HT as a bone graft material in the treatment of periodontal vertical defects and its clinical and radiological evaluation: Clinical study.

Authors:  K T Chandrashekar; Chhavi Saxena
Journal:  J Indian Soc Periodontol       Date:  2009-09

7.  Clinical evaluation of regenerative potential of type I collagen membrane along with xenogenic bone graft in the treatment of periodontal intrabony defects assessed with surgical re-entry and radiographic linear and densitometric analysis.

Authors:  N K Sowmya; A B Tarun Kumar; D S Mehta
Journal:  J Indian Soc Periodontol       Date:  2010-01

8.  Influence of surface microstructure on the reaction of the active ceramics in vivo.

Authors:  H Yokozeki; T Hayashi; T Nakagawa; H Kurosawa; K Shibuya; K Ioku
Journal:  J Mater Sci Mater Med       Date:  1998-07       Impact factor: 3.896

Review 9.  Calcium orthophosphates in dentistry.

Authors:  Sergey V Dorozhkin
Journal:  J Mater Sci Mater Med       Date:  2013-03-07       Impact factor: 3.896

10.  Clinical evaluation of anorganic bovine-derived hydroxyapatite matrix/cell-binding peptide (P-15) in the treatment of human infrabony defects.

Authors:  Adrian Kasaj; Bernd Röhrig; Christoph Reichert; Brita Willershausen
Journal:  Clin Oral Investig       Date:  2008-03-05       Impact factor: 3.573

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.